A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia
Status:
Completed
Trial end date:
1997-03-01
Target enrollment:
Participant gender:
Summary
Objective - Type 2 uncontrolled diabetic patients often have low endogenous melatonin and
suffer from sleep disorders. The effect of a prolonged-release melatonin (PRM) formulation on
glucose lipid metabolism and sleep is studied in type 2 diabetes patients with insomnia.